MEN with aggressive prostate cancer could benefit from a new drug combination that slows cancer growth, scientists say. Adding a drug already used against ovarian and fallopian tube cancers to ...
Manchester City is proud to stand with Prostate Cancer UK by supporting Prostate United 2025 — a nationwide fundraising challenge uniting football clubs and fans to help save men's lives.Every 45 ...
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL ...
Jason Yeo, 54, a travelling sales manager from Devon, was shocked to discover his diagnosis in April 2024. He previously considered himself healthy, sporty, and entirely “symptomless”, and was ...
The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for more than a dozen cancer types, along ...
The article wrongly said a study claimed to have found proof the vaccines raised the risk of getting several types of cancer.
Former Premier League striker Andy Cole and radio and TV star DJ Spoony were among 80 golfers at The Addington raising awareness of the increased risk of prostate cancer in the black community.
DNA blood test identifies chronic fatigue syndrome with 96% accuracy. Early results need larger trials before clinical use.
From daily happiness habits to tips for nurturing contented teams, OT explores how practitioners can maintain their mental and physical health ...
WarwickshireWorld on MSN

Young students come to lunch

Final year students from Warwick School, Kings High, Myton School and Kingsley together with their teachers, joined Rotarians for lunch last Wednesday and were introduced by Youth lead Rotarian Laurie ...
Although many people in Milton Keynes will know that Willen Hospice provides palliative and end-of-life care, they might not realise that this includes a wide range of therapeutic and wellbeing ...
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL ...